Nanopharm

Nanopharm, an Aptar company, integrated development services in materials characterisation, formulation development and inhaled biopharmaceutics for tailored analytical and drug development services, with a focus on orally inhaled and nasal drug products.


Visit Website



Associated Companies

  Aptar Pharma  

Headquarters
Nanopharm Ltd, an Aptar Company
Imperial House
Imperial Way
Coedkernew, Newport
NP10 8UH
United Kingdom

Phone / Contact

T: +44 1633 504 776
E: [email protected]

Connect

Nanopharm provides tailored analytical and drug development services, with a focus on orally inhaled and nasal drug products. The company’s unique processing technologies and formulation development tools enable translation of preclinical development through to clinical manufacturing.

Nanopharm’s integrated development services in materials characterisation, formulation development and inhaled biopharmaceutics aid successful product development by enabling its client to understand how material properties and processing conditions influence product functionality.

In June 2019, the company was acquired by Aptar Pharma.

Top